D. Boral Capital Maintains Buy on MediciNova, Maintains $9 Price Target

Benzinga · 12/08/2025 16:16
D. Boral Capital analyst Jason Kolbert maintains MediciNova (NASDAQ:MNOV) with a Buy and maintains $9 price target.